Saeed Dabestani

Medicin och livsvetenskap

1. Renal Cell Carcinoma 100%
2. Urology 65%
3. Guidelines 37%
4. Systematic Reviews 36%
5. Clear-cell metastatic renal cell carcinoma 31%
6. Kidney Neoplasms 29%
7. Nivolumab 23%
8. Recurrence 23%
9. Survival 20%
10. Nephrectomy 18%
11. cabozantinib 18%
12. pembrolizumab 16%
13. Metastasectomy 16%
14. Databases 16%
15. Sunitinib 15%
16. Standard of Care 14%
17. Ipilimumab 13%
18. Neoplasm Metastasis 10%
19. Therapeutics 10%
20. Neoplasms 9%
21. Axitinib 9%
22. Meta-Analysis 9%
23. Kidney 8%
24. Uncertainty 6%
25. Prostatic Neoplasms 6%
26. Disease-Free Survival 6%
27. Randomized Controlled Trials 6%
28. Ureteroscopy 5%
29. Confidence Intervals 5%
30. Percutaneous Nephrolithotomy 5%
31. Urolithiasis 5%
32. Progression-Free Survival 5%